Jennifer Sexton

Diretora/CAS Custom Services

Bio

Como parte do CAS Custom Services, Jennifer projeta soluções individualizadas para clientes com o aproveitamento do conteúdo do CAS, a tecnologia e os especialistas em assuntos para resolver complexos desafios de P&D e negócios. Jen ingressou no CAS Custom Services em 2020 após passar mais de uma década como gerente de contas estratégicas. Parte de sua função anterior incluía redigir e oferecer treinamento técnico para clientes nas plataformas de software CAS STN e CAS SciFinder®.

Jennifer tem mestrado em ciências em química pela Universidade de Notre Dame. Ela tem bacharelado em ciências em química e um bacharelado em artes em psicologia pela Universidade Estadual de Southwest Minnesota. Ela é membro do Grupo de Usuários de Informação de Patentes (PIUG) e da Sociedade Americana de Química (ACS).

Biotecnologia

Creating resilience and efficiency in biotech supply chains

Discover how custom digital solutions can help companies build resilient and efficient biotech supply chains while accelerating innovation.
|Artigo
Read the CAS Insights article
P&D digital

AI in Pharma: Data strategies fuel successful drug repurposing

Discover how artificial intelligence in pharma can enhance drug repurposing by leveraging dark data, ensuring data diversity, and improving data quality.
|Artigo
Read the CAS Insights article
P&D digital

Emerging trends in global biothreat detection

Learn how emerging trends in AI are impacting CBRNE threat detection and mitigation.
|Artigo
Read the CAS Insights article
P&D digital

Predicting and countering chemical threats: The strategic role of data-driven technologies

Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.
|Artigo
Read the CAS Insights article
P&D digital

Reducing waste through digital transformation

Learn how digital transformation is reducing waste and creating new revenue streams for companies as they repurpose waste byproducts.
|Artigo
Read the CAS Insights article
P&D digital

Making pharmaceutical formulation data discoverable

Pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once-hidden knowledge into drug discoveries.
|Artigo
Read the CAS Insights article
P&D digital

R&D Trends: Maximizing dark data to enhance drug repurposing

As the drug repurposing market grows, pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once hidden insights into drug repurposing innovations.
|Artigo
Read the CAS Insights article
P&D digital

Digital transformation in the chemical industry: Steps to a sustainable future

Digital initiatives are transforming the chemical industry, allowing for faster innovation and a sustainable future.
|Artigo
Read the CAS Insights article
P&D digital

Pharma data management: Revealing breakthroughs that lie in darkness

Strategies to unlock dark data in the pharmaceutical industry. Reveal data insights and accelerate innovation through digitization and knowledge management.
|Artigo
Read the CAS Insights article
P&D digital

Digital transformation in pharma: Improving R&D through digital solutions

Digital initiatives are transforming the pharmaceutical industry, allowing for faster drug development and expanded treatment options.
|Artigo
Read the CAS Insights article
P&D digital

Dark data: Uncovering hidden R&D value

Research and development teams amass huge quantities of complex data which, if exploited correctly, can be a useful information source to improve decision-making and drive innovation.
|Artigo
Read the CAS Insights article